Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2
- 29 September 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 348 (3), 1075-1081
- https://doi.org/10.1016/j.bbrc.2006.07.181
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinomaCancer, 2004
- Biliary nitrate and risk of carcinoma of the gallbladderEuropean Journal of Cancer Prevention, 2004
- Squamous Cell Carcinoma of GallbladderJournal of Nippon Medical School, 2004
- Paclitaxel Inhibits Proliferation of Cell Lines Responsible for Metal Stent Obstruction:Investigative Radiology, 2002
- Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosageLeukemia, 2001
- Clinical Experience of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaThe Oncologist, 2001
- Introduction: The History of Arsenic Trioxide in Cancer TherapyThe Oncologist, 2001
- Chemotherapy with gemcitabine in patients with advanced gallbladder carcinomaZeitschrift für Gastroenterologie, 2000
- Epidemiologic Aspects of Gallbladder Cancer: A Case-Control Study of the SEARCH Program of the International Agency for Research on CancerJNCI Journal of the National Cancer Institute, 1997
- Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancerCancer, 1984